Press Releases

May 27, 2020
Bicycle Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, England & BOSTON --(BUSINESS WIRE)--May 27, 2020-- Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ®) technology, today announced that management will
Apr 23, 2020
Bicycle Therapeutics Appoints Zafar Qadir as General Counsel
CAMBRIDGE, England & BOSTON --(BUSINESS WIRE)--Apr. 23, 2020-- Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today announced the appointment of Zafar
Displaying 1 - 10 of 15